by DivRank | May 20, 2025 | Downgrades
Jefferies has lowered its rating on AES Corp. from “Hold” to “Underperform,” cutting the price target to \$9. This shift follows a sharp 15% rally in the stock, spurred by optimism around a newly proposed tax bill. However, analysts are cautioning that this bump in...
by DivRank | May 15, 2025 | Downgrades
Oppenheimer has revised its rating on Ares Management (ARES) from “Outperform” to “Perform,” pointing to concerns that the stock’s valuation has outpaced its earnings potential. While Ares continues to deliver solid financials, the downgrade...
by DivRank | May 14, 2025 | Downgrades
UnitedHealth Group (NYSE: UNH) is under heavy investor scrutiny following back-to-back downgrades and a significant plunge in share price. Once a staple of stability in the healthcare sector, the stock has tumbled nearly 40% year-to-date, now among the worst...
by DivRank | May 14, 2025 | Downgrades
KeyBanc Capital Markets has downgraded Portland General Electric (NYSE: POR) from Overweight to Sector Weight, citing jurisdictional challenges that could impact the company’s regulatory environment and growth prospects. Despite a 16.4% increase in industrial...
by DivRank | May 14, 2025 | Downgrades
Citigroup has downgraded Merck & Co. from “Buy” to “Neutral,” with a revised price target of \$84. This move centers on the looming 2028 loss of exclusivity for Merck’s cornerstone cancer drug, Keytruda. Though the market has partially...
by DivRank | May 14, 2025 | Downgrades
On May 14, 2025, KeyBanc Capital Markets lowered its rating on Consolidated Edison from “Sector Weight” to “Underweight,” setting a price target of \$90. 🔍 The downgrade reflects growing concerns over regulatory risks, particularly stemming...
